ClinicalTrials.gg
Sign In

Drug

Anti-EGFR/CD16A Bispecific Antibody AFM24 clinical trials

Also written AFM24.

studies test it
3
open now
0
in phase 3
0
first study started
2020

How studies write it

Studies that test it under each name

Development codes

AFM24
2

Studies by the year they started

3 studies that test it; most in 2021 (2)

Studies that test Anti-EGFR/CD16A Bispecific Antibody AFM24, by start year
YearStudies
20201
20212

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Squamous Cell Carcinoma of Head and Neck
1

Who runs them

Industry 3 · Other 0

Affimed GmbH (2) · NKGen Biotech, Inc. (1)

Often tested with

Tested in the same studies.

Atezolizumab (1) · Troculeucel (1)

Studies

Open first, then newest update. How each study uses Anti-EGFR/CD16A Bispecific Antibody AFM24 is read from its arms, and is right about nine times in ten.

Testing it · 3